Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

While it may not be a steal of a deal, with the business on the cusp of some exciting growth, Johnson & Johnson's stock could ...

Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. On February 3, RBC Capital raised its price target on Johnson & Johnson (NYSE:JNJ) to $255 from $240 ...

Johnson & Johnson (NYSE:JNJ) is one of the 10 Hottest Stocks to Buy in 2026. On January 28, TheFly reported that Morgan ...

Johnson and Johnson stock reached a significant milestone by hitting an all-time high of $239.65, just pennies above its 52-week high of $239.58. This achievement underscores a remarkable period of ...

(Reuters) -A Los Angeles jury late on Monday ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest lawsuit ...

As Johnson & Johnson seeks city incentives to help expand its Jacksonville-based vision products subsidiary, company officials are touting the growth potential of the unit.

Johnson & Johnson remains a buy as business momentum accelerates, with Q4 revenue up 9.1% YoY and strong U.S. sales ...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the Company’s intent to separate its Orthopaedics business to enhance the strategic and operational ...

Health care giant Johnson & Johnson (NYSE:JNJ) has had a good year with its shares trading near all-time highs. The company looks to keep a trend of beating analyst estimates when third-quarter ...

Johnson & Johnson has announced plans to split into two companies, spinning off its consumer health division—which sells products like Band-Aids, Baby Powder, and Listerine—into a separate publicly ...

(Reuters) -A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial alleging its talc ...